Published on in Vol 9 (2023)
![Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study](https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 480w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 960w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 1920w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 2500w)
1 Centre for Health Management and Policy Research, School of Public Health,Cheeloo College of Medicine, Shandong University, Jinan, China
2 NHC Key Laboratory of Health Economics and Policy Research, Shandong University, Jinan, China
3 Centre for Health Preference Research, Shandong University, Jinan, China
4 School of Public Health, Fudan University, Shanghai, China
5 NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China
6 Macquarie University Centre for the Health Economy, Macquarie Business School and Australian Institute of Health Innovation, Macquarie University, Sydney, Australia
7 Shandong Hemophilia Treatment Center, Shandong Blood Center, Jinan, China
*these authors contributed equally